- American Society for Transplantation and Cellular Therapy
- American Society of Clinical Oncology
- American Society of Hematology
- American Society of Pediatric Hematology/Oncology
- Children’s Oncology Group
Tanya Watt, M.D.
- Dedman Family Scholar in Clinical Care
- Pediatrics - Hematology-Oncology
- Neuroblastoma
- Pediatric cancer
Biography
Tanya Carens Watt, M.D., is an Associate Professor in the Department of Pediatrics at UT Southwestern Medical Center. She specializes in pediatric oncology.
Dr. Watt earned her medical degree at the UT Health Science Center at San Antonio. She completed both her a residency in pediatrics and fellowship in pediatric hematology and oncology at Emory University. She also holds a Master of Science in clinical research.
Certified by the American Board of Pediatrics in pediatric hematology-oncology, she joined the UT Southwestern faculty in 2011.
Dr. Watt serves as the Fellowship Program Director for the Division of Hematology and Oncology in the Department of Pediatrics. She is a member of several professional organizations, including the American Society of Clinical Oncology, the American Society of Pediatric Hematology Oncology, the Children’s Oncology Group, and the American Society of Hematology.
Dr. Watt’s clinical and research interests include pediatric cancer, especially neuroblastoma, about which she has written several articles and case reports and made presentations,. She is also invested in improving education for pediatric hematology-oncology fellows and has published on ways to train physicians better.
Education & Training
- Residency - Emory University School of Medicine (2003-2006), Pediatrics
- Medical School - UT Health Science Center at San Antonio (1999-2003)
- Fellowship - Emory University School of Medicine (2006-2009), Pediatric Hematology/oncology
Professional Associations & Affiliations
Honors & Awards
- D Magazine Best Pediatric Specialist 2021
- D Magazine Best Doctor, 2019-2020, 2022-2025
- Nominated Medical Executive Staff President 2019, Children’s Health
- Fellow’s Teaching Award 2015, UT Southwestern
- Dedman Family Scholar 2011, UT Southwestern
- Hope on Wheels Scholar 2009, Hyundai
- Sam Robb Research Fellow 2008, CURE Childhood Cancer
- Research Fellow 2007, CURE Childhood Cancer
- Senior Resident of the Year 2006, Emory University
- Mary Brady Award 2006, Emory University
- Chief Resident 2005, Emory University
- Apgar Award 2004, Emory University
Books & Publications
-
Publications
-
Use of PULSAR (personalized ultra-fractionated stereotactic adaptive radiotherapy) as consolidation with immune checkpoint inhibition in the treatment of pediatric metastatic melanoma
McCarty KL, Watt T, Dan TD, Timmerman RD, Kumar KA Radiation Oncology 2025 Dec 20 -
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Dela Cruz FS, Fox E, DuBois SG, Friedman GK, Croop JM, Kim AR, Morgenstern DA, Balis FM, Macy ME, Pressey JG, Watt T, Krystal JI, Vo KT, Mody R, Laetsch TW, Weigel BJ, O'Hara K, He CS, Aluri J, Okpara CE, Glade Bender JL Pediatric Blood and Cancer 2025 Jul 72 -
Neuroblastoma, Version 2.2024
Bagatell R, Park JR, Acharya S, Aldrink J, Allison J, Alva E, Arndt C, Benedetti D, Brown E, Cho S, Church A, Davidoff A, Desai AV, DuBois S, Fair D, Farinhas J, Harrison D, Huang F, Iskander P, Kreissman S, Macy M, Na B, Pashankar F, Pendyala P, Pinto N, Polites S, Rabah R, Shimada H, Slatnick L, Sokol E, Twist C, Vo K, Watt T, Wolden S, Zage P, Schonfeld R, Hang L JNCCN Journal of the National Comprehensive Cancer Network 2024 Aug 22 413-433 -
Pain mitigation and management strategies for anti-GD2 infusions: An expert consensus
Nysom K, Morad AG, Rafael MS, Zier J, Marachelian A, Watt T, Morgenstern DA Pediatric Blood and Cancer 2023 May 70 -
An Unusual Case of Late Recurrence of MS Neuroblastoma in a Young Adult
Boulter AC, Watt T Journal of Pediatric Hematology/Oncology 2023 Jan 45 E124-E125 -
Pediatric Non-Myofibroblastic Primitive Spindle Cell Tumors with ALK Gene Rearrangements and Response to Crizotinib
Rakheja D, Park JY, Fernandes NJ, Watt TC, Laetsch TW, Collins RR International Journal of Surgical Pathology 2022 Sep 30 706-715 -
Recent progress in the treatment of cancer in children
Butler E, Ludwig K, Pacenta HL, Klesse LJ, Watt TC, Laetsch TW CA Cancer Journal for Clinicians 2021 Jul 71 315-332 -
Isotope tracing reveals glycolysis and oxidative metabolism in childhood tumors of multiple histologies
Johnston K, Pachnis P, Tasdogan A, Faubert B, Zacharias LG, Vu HS, Rodgers-Augustyniak L, Johnson A, Huang F, Ricciardo S, Zhao Z, Mathews TP, Watt T, Leavey P, DeBerardinis RJ Med 2021 Apr 2 395-410.e4 -
Infant with an unusual pharyngeal mass
Shields BB, Lampson EE, Sengupta AL, Watt TC, Mitchell RB Ear, Nose and Throat Journal 2018 Jun 97 154-155 -
Radiation-related new primary solid cancers in the childhood cancer survivor study: Comparative radiation dose response and modification of treatment effects
Inskip PD, Sigurdson AJ, Veiga L, Bhatti P, Ronckers C, Rajaraman P, Boukheris H, Stovall M, Smith S, Hammond S, Henderson TO, Watt TC, Mertens AC, Leisenring W, Stratton K, Whitton J, Donaldson SS, Armstrong GT, Robison LL, Neglia JP International Journal of Radiation Oncology Biology Physics 2016 Mar 94 800-807 -
Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia
Tarlock K, Chang B, Cooper T, Gross T, Gupta S, Neudorf S, Adlard K, Ho PA, Mcgoldrick S, Watt T, Templeman T, Sisler I, Garee A, Thomson B, Woolfrey A, Estey E, Meshinchi S, Pollard JA Pediatric Blood and Cancer 2015 Jun 62 1048-1054 -
Humanism and professionalism education for pediatric hematology-oncology fellows: A model for pediatric subspecialty training
Kesselheim JC, Atlas M, Adams D, Aygun B, Barfield R, Eisenman K, Fulbright J, Garvey K, Kersun L, Nageswara Rao A, Reilly A, Sharma M, Shereck E, Wang M, Watt T, Leavey P Pediatric Blood and Cancer 2015 Feb 62 335-340 -
Sorafenib as treatment for relapsed or refractory pediatric acute myelogenous leukemia
Watt TC, Cooper T Pediatric Blood and Cancer 2012 Oct 59 756-757 -
Radiation-related risk of basal cell carcinoma: A report from the childhood cancer survivor study
Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, Stovall M, Leisenring W, Robison LL, Mertens AC Journal of the National Cancer Institute 2012 Aug 104 1240-1250 -
PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells
Crosswell HE, Dasgupta A, Alvarado CS, Watt T, Christensen JG, De P, Durden DL, Findley HW BMC Cancer 2009 Nov 9 -
Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin
Watt T, Warshaw B, Katzenstein HM Pediatric Blood and Cancer 2009 Jul 53 90-91
-
Use of PULSAR (personalized ultra-fractionated stereotactic adaptive radiotherapy) as consolidation with immune checkpoint inhibition in the treatment of pediatric metastatic melanoma
Research
- Neuroblastoma
- Pediatric cancer
- Medical education
Clinical Focus
- Neuroblastoma
- Pediatric cancer
- Pediatrics
Children's Medical Center of Dallas
1935 Medical District DriveDallas, Texas 75235 214-730-5437 Directions to Children's Medical Center of Dallas at Children's Medical Center of Dallas, Dallas